BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

Letrozole: trial readouts and FDA decisions

5 upcoming industry Phase 2/3 readout(s) in the next 90 days, 0 upcoming FDA event(s), 1 readout(s) in the last 180 days and 0 FDA event(s) in the last 12 months. Sponsors: Pfizer, Jiangsu HengRui Medicine Co., Ltd., Tolmar Inc., Olema Oncology, Inc., Jiangsu HengRui Medicine Co., Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Olema Oncology, Inc.. Drug names come from ClinicalTrials.gov intervention names and FDA records, lightly normalised; one drug can appear under several names (code, generic, brand).

Upcoming trial readouts

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-12 est.P1/P2Jiangsu HengRui Medicine Co., Ltd.NCT06974929 A Clinical Study of HRS-6209 Combined With Other Treatment Regimens in Patients With Breast CancerBreast Cancerrecruiting80
2026-12-30 est.P3Pfizer PFENCT05909397 Vepdegestrant (ARV-471/PF-07850327) + Palbociclib vs Letrozole + Palbociclib in ER(+)/HER2(-) Advanced Breast CancerBreast Canceractive not recruiting59
2026-12-31 est.P2Pfizer PFENCT04553133 PF-07104091 as a Single Agent and in Combination TherapySmall Cell Lung Cancer; Ovarian Cancer; Breast Canceractive not recruiting157
2027-01-30 est.P3Tolmar Inc.NCT04906395 Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast CancerBreast Canceractive not recruiting250
2026-12 est.P3Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT05780567 Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast CancBreast Canceractive not recruiting1946

Readouts, last 180 days

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-10-31 est.P3Olema Oncology, Inc. OLMANCT06016738 OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast CancerBreast Cancer; Advanced Breast Cancer; Metastatic Breast Cancer; ER Positive Breast Cancer; HER2 Negactive not recruiting510

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.